Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHF.
Sotagliflozin 對於心臟衰竭惡化患者健康狀態的影響:來自 SOLOIST-WHF 的結果。
J Am Coll Cardiol 2024-09-11
Quantitative effects of sodium-glucose cotransporter-2 inhibitors dapagliflozin and empagliflozin on quality of life in heart failure patients.
SGLT-2 抑制劑 dapagliflozin 和 empagliflozin 對心臟衰竭患者生活品質的定量影響。
Front Pharmacol 2022-12-21
Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction.
Dapagliflozin對保留或輕度降低射血分數患者健康狀況的影響。
J Am Coll Cardiol 2023-04-03
Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHF.
Sotagliflozin對早期死亡率和與心力衰竭相關事件的影響:SOLOIST-WHF後設分析。
JACC Heart Fail 2023-09-07
Efficacy of Sotagliflozin in Adults With Type 2 Diabetes in Relation to Baseline Hemoglobin A1c.
Sotagliflozin在成人2型糖尿病患者中相對於基線血紅素A1c的療效。
J Am Coll Cardiol 2023-11-12
Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials.
心衰患者中鈉葡萄糖共同運輸蛋白2抑制劑與生活品質:隨機對照試驗的全面系統性回顧和荟萃分析。
Eur Heart J Cardiovasc Pharmacother 2024-02-26
Sotagliflozin: Efficacy, Safety, and Potential Therapeutic Applications in Heart Failure.
Sotagliflozin:心力衰竭中的療效、安全性和潛在治療應用。
Ann Pharmacother 2023-12-21
Early Longitudinal Change in Heart Failure Health Status Following Initiation of Canagliflozin.
Canagliflozin 開始治療後心衰健康狀態的早期縱向變化。
JACC Heart Fail 2024-04-05
Impact of SGLT2 Inhibitors on Quality of Life in Heart Failure Across the Ejection Fraction Spectrum: Systematic Review and Meta-analysis.
SGLT2抑制劑對心臟衰竭患者在射血分數範圍內的生活品質影響:系統性回顧與荟萃分析。
CJC Open 2024-05-06
Meta-analysis of sotagliflozin, a dual sodium-glucose-cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes.
sotagliflozin:一種雙重鈉-葡萄糖共轉運蛋白 1/2 抑制劑,對於 2 型糖尿病心衰竭的統合分析。
ESC Heart Fail 2024-09-11